Oncology Molecular Diagnostics Global Market 2024 To Reach $7.99 Billion By 2028 At Rate Of 13.3%

November 05, 2024 12:45 PM AEDT | By EIN Presswire
 Oncology Molecular Diagnostics Global Market 2024 To Reach $7.99 Billion By 2028 At Rate Of 13.3%
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, November 5, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

The oncology molecular diagnostics market has expanded significantly in recent years. It is projected to increase from $4.19 billion in 2023 to $4.84 billion in 2024, reflecting a compound annual growth rate (CAGR) of 15.6%. The growth during the historical period can be attributed to the introduction of early tests, advancements in genomic profiling, the launch of next-generation sequencing (NGS), early biomarker identification, and the development of targeted therapies.

What Is the Estimated Growth Rate and Market Size of the Global Oncology Molecular Diagnostics Market?
The oncology molecular diagnostics market is anticipated to experience substantial growth in the coming years. It is projected to reach $7.99 billion by 2028, with a compound annual growth rate (CAGR) of 13.3%. This growth during the forecast period can be linked to advancements in liquid biopsy, the increasing use of companion diagnostics, the integration of artificial intelligence (AI), the expansion of next-generation sequencing (NGS) applications, and the evolution of biomarker identification.

Access Key Market Data and Trends with a Free Sample Report on the Global Oncology Molecular Diagnostics Market:
https://www.thebusinessresearchcompany.com/sample_request?id=3457&type=smp

What Are The Significant Drivers Behind The Growth Of The Oncology Molecular Diagnostics Market?
The rising demand for personalized medicine is anticipated to drive the growth of the oncology molecular diagnostics market in the future. Personalized medicine is a cutting-edge approach to healthcare that customizes medical decisions, practices, interventions, and drug therapies to the individual patient. Oncology molecular diagnostics play a crucial role in the era of personalized medicine for cancer patients by offering tailored treatment plans, optimized drug selection, and more precise, effective, and individualized treatment strategies, ultimately enhancing patient outcomes and quality of life.

Pre-book the report for a swift delivery:
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Which Top Companies Are Shaping The Growth Of The Oncology Molecular Diagnostics Market?
Key players in the oncology molecular diagnostics market include F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Charles River Laboratories India Pvt. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.vv

Which Emerging Trends Are Reshaping the Oncology Molecular Diagnostics Market Size?
Key players in the oncology molecular diagnostics market are concentrating on developing innovative products, including oncology liquid biopsy solutions, to boost their revenues. Oncology liquid biopsy products are advanced diagnostic tools and tests that facilitate the non-invasive detection and monitoring of cancer by analyzing various biomarkers and genetic material.

What Are The Segments In The Global Oncology Molecular Diagnostics Market?
1) By Product: Instruments, Reagents, Other Products
2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users

North America: Largest Region in the Oncology Molecular Diagnostics Market

North America was the largest region in the market in 2023. Western Europe was the second largest region in the report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is The Oncology Molecular Diagnostics Market Defined?
Oncology molecular diagnostics refers to procedures used for diagnosing cancers and associated services. Molecular diagnostics involve tests that analyze genetic information, proteins, or related molecules, offering insights into health conditions or diseases.

The Oncology Molecular Diagnostics Global Market Report 2024 from The Business Research Company includes the following key information:
• Market size data for both historical and future periods
• Analysis of both macro and microeconomic factors that have impacted the market over the past five years
• Regional market analysis covering Asia-Pacific, China, Western Europe, Eastern Europe, North America, the USA, South America, and the Middle East and Africa
• Country-specific market analysis for Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

Overview of the Global Oncology Molecular Diagnostics Market Report: Trends, Opportunities, Strategies, and More
The Oncology Molecular Diagnostics Global Market Report 2024 from The Business Research Company is an extensive resource that delivers insights into oncology molecular diagnostics market size, oncology molecular diagnostics market drivers and trends, oncology molecular diagnostics competitors' revenues, and oncology molecular diagnostics market growth across geographies. This report provides valuable in-depth insights into potential opportunities and strategies. Companies can utilize the information presented to target segments with the greatest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Medical Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

What Services Does The Business Research Company Offer?
The Business Research Company has published more than 15,000 reports spanning 27 industries and over 60 regions. Our research is supported by 1.5 million datasets, thorough secondary research, and unique insights gained from interviews with industry experts. We offer ongoing and customized research services, featuring a variety of specialized packages designed to meet your specific needs, such as Market Entry Research, Competitor Tracking, Supplier & Distributor Packages, and many others.

Our flagship product, the Global Market Model, serves as a leading market intelligence platform that provides comprehensive and updated forecasts to facilitate informed decision-making

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.